Skip to content

Circles

M

Milestone Pharmaceuticals Inc.

MIST· Nasdaq

M

MISTMilestone Pharmaceuticals Inc.

MISTMilestone Pharmaceuticals Inc.·Earnings record

Q2 2018

Source filing unavailable

Previous · Q1 2018 Next · Q3 2018

Q2 2018 · —

Revenue—

Net Income

-$3.59M

no prior Q2 2017 on file

EPS Diluted

-$12.71

no prior Q2 2017 on file

Operating Income-$3,676,000—

Operating Cash Flowderived-$3,421,000—

Free Cash Flowderived

Same quarter

no prior Q2 2017 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Filing lag

Quarterly history

Q1 ’18Q2 ’18Q3 ’18 Q4 ’18^d Q1 ’19 Q2 ’19 Q3 ’19 Q4 ’19^d Q1 ’20…

Milestone Pharmaceuticals Inc. · CIK 1408443 · Engraved from SEC EDGAR

-$3,421,000

—

Thaler ResearchEngraved from SEC EDGAR© 2026 Thaler. All rights reserved.Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Platform

Using AI API SDKs CLI

Research

News Listen Earnings Insiders Holders Compare Metrics

Screener Watchlists Pies Notes Your companies

Learn

Thaler

Thaler Agent Promise Provenance Circles Account Terms Privacy